IHC

ATRX

ATRX mutations are characteristic of grade II/III astrocytomas and secondary glioblastomas, while loss of ATRX expression defines a subset of astrocytic tumors associated with more favorable outcomes.

Full Description

ATRX mutations are characteristic of grade II/III astrocytomas and secondary glioblastomas, while loss of ATRX expression defines a subset of astrocytic tumors associated with more favorable outcomes.

Methodology

IHC

Specimen Requirements

Tissue Block: Formalin-fixed, paraffin-embedded (FFPE) tumor block preferred. Unstained Slides: Recommended 2charged slides per stain requested (minimum of 1 slide per stain),baked or unbaked. Fixation: Tissue must be fixed in 10% neutral buffered formalin for 6–72 hours.

Storage and Transportation

Use cold pack for transport, making sure cold pack is not in direct contact with specimen.

Turnaround Time

Tech-Only (stain only): 24 hrs

CPT Codes

88342x1 or 88341x1